Karyopharm Therapeutics (KPTI) PT Lowered to $14 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Karyopharm Therapeutics (KPTI) Announces Michael P. Mason as SVP, CFO and Treasurer
February 25, 2019 7:08 AM ESTKaryopharm Therapeutics Inc. (NASDAQ: KPTI) today announced the appointment of Michael P. Mason as Senior Vice President, Chief Financial Officer and Treasurer. In this role, Mr. Mason will be responsible for leading and directing the financial activities of the Company.
Mr. Mason brings to Karyopharm more than 18 years of diversified financial experience in executing financial strategies and leading growth initiatives for life sciences companies. Most recently,... More
